Beth Seidenberg and Sean Harper (Westlake Village)

Cor­rect­ed: West­lake tar­gets $450M for Sei­den­berg's next life sci­ences fund

Life sci­ences VC firm West­lake Vil­lage BioPart­ners is ready to re­stock its cap­i­tal re­serves short­ly af­ter its suc­cess with bring­ing port­fo­lio com­pa­ny Ace­lyrin to one …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.